Anti-TNF biosimilars: Exploring the possibilities
Join Professor Peter Taylor and a panel of experts as they discuss anti-tumour necrosis factor (TNF) biosimilars in rheumatic disease, looking at anti-TNF best practice and the impact of biosimilars for patients and healthcare professionals.
Listen on:
Episodes
Monday Oct 09, 2023
Monday Oct 09, 2023
“The complexity of a biologic molecule is such that it’s impossible to make exact copies.” Professor Peter Taylor and Professor Hans Bijlsma consider anti-TNF biosimilars – the regulatory process, guidelines, uptake within healthcare systems and the resulting impact on patient health and wellbeing.
Monday Oct 09, 2023
Monday Oct 09, 2023
Hear about the armamentarium of biological therapies available for the treatment of rheumatic disease, including biological DMARDs (disease-modifying antirheumatic drugs), and how they may slow the progression of arthritis. Professor Peter Taylor and Professor Rieke Alten discuss how different anti-TNFs may better suit different patients and the issue of anti-drug antibodies.
Your Title
This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.